MedTrace Logo

Lutein Supplementation in Healthy Children

NCT05314647 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 59

Last updated 2023-11-30

No results posted yet for this study

Summary

This is a single site, randomized, double-blind placebo controlled parallel arm study assessing the effects of 6 months lutein supplementation on cognitive and visual outcomes in healthy children exposed to excessive digital screen time.

Conditions

  • Eye Fatigue
  • Diet, Healthy
  • Cognitive Change

Interventions

DIETARY_SUPPLEMENT

lutein

daily dose of 5 mg lutein

DIETARY_SUPPLEMENT

placebo

daily dose of 0 mg lutein

Sponsors & Collaborators

  • Northcentral University

    lead OTHER

Principal Investigators

  • Patrick McNamara, PhD · Northcentral University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
8 Years
Max Age
16 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-07-15
Primary Completion
2024-03-31
Completion
2024-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05314647 on ClinicalTrials.gov